Oral contraceptives combined with interferon β in multiple sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 28, 2014
- Accepted in final form May 4, 2015
- First Published June 18, 2015.
Author Disclosures
- Carlo Pozzilli, MD, PhD,
- Laura De Giglio, MD, PhD,
- Valeria T. Barletta, MD,
- Fabiana Marinelli, MD,
- Floriana De Angelis, MD,
- Valentina Gallo, MD, PhD,
- Veronica A. Pagano, MSc,
- Stefano Marini, MSc,
- Maria C. Piattella, MD, PhD,
- Valentina Tomassini, MD, PhD and
- Patrizia Pantano, MD
- Carlo Pozzilli, MD, PhD,
Novartis, Merck Serono, Biogen, Bayer, Sanofi-Aventis,Teva
NONE
Novartis, Merck Serono, Biogen, Bayer ,Sanofi Aventis, Teva
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Biogen Idec, Merck Serono, Bayer, Novartis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Laura De Giglio, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Valeria T. Barletta, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fabiana Marinelli, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Floriana De Angelis, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Valentina Gallo, MD, PhD,
NONE
NONE
NONE
(1) Conference Papers in Medicine, Editor, 2012 (2) World Journal of Neurology, Editor, 2012 (3) Dataset papers in Medicine, Editor, 2012 (4) Word Journal of Meta-Analysis, Editor, 2013 (5) Clinical Epidemiology Reviews, Editor, 2013 (6) International Journal of Neurology Research, Editor, 2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Veronica A. Pagano, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefano Marini, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maria C. Piattella, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Valentina Tomassini, MD, PhD and
Served on a scientific advisory board for Biogen.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research grants or fellowship from the Italian Ministry of Health; MS Society Italy; MS Society UK; MS International Federation; Cardiff University Funds.
NONE
Research grants or fellowship from the MS Society Italy; MS Society UK; MS International Federation.
NONE
NONE
NONE
NONE
NONE
NONE
- Patrizia Pantano, MD
NONE
NONE
1. Byogen, speaker honorary
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology and Psychiatry (C.P., L.D.G., F.D.A., M.C.P., V.T., P.P.), Sapienza University of Rome, Italy; MS Center (C.P., L.D.G., V.T.B., F.M.), S. Andrea Hospital, Sapienza University of Rome, Italy; Centre for Primary Care and Public Health (V.G.), Queen Mary University of London, UK; TFS Trial Form Support S.L. (V.A.P., S.M.), Rome, Italy; Institute of Psychological Medicine and Clinical Neurosciences (V.T.), Cardiff University School of Medicine University Hospital of Wales (V.T.), Cardiff, UK; Santa Lucia Foundation (V.T.), Rome, Italy; and IRCCS Neuromed (P.P.), Pozzilli (IS), Italy.
- Correspondence to Dr. Pozzilli: carlo.pozzilli{at}uniroma1.it
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MSD. H. Miller, D. Soon, K. T. Fernando et al.Neurology, April 23, 2007 -
Articles
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapsesP. W. O’Connor, D. Li, M. S. Freedman et al.Neurology, March 27, 2006 -
Articles
Randomized multicenter trial of natalizumab in acute MS relapsesClinical and MRI effectsP. W. O’Connor, A. Goodman, A. J. Willmer-Hulme et al.Neurology, June 07, 2004 -
Articles
Randomized, comparative study of interferon β-1a treatment regimens in MSThe EVIDENCE TrialH. Panitch, D.S. Goodin, G. Francis et al.Neurology, November 26, 2002